These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11474314)

  • 21. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drug-induced gastropathy: a comparative endoscopic and histopathological evaluation of the effects of tenoxicam and diclofenac.
    al-Quorain AA; Satti MB; Marwah S; al-Nahdi M; al-Habdan I
    J Int Med Res; 1993; 21(2):89-97. PubMed ID: 8243794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers.
    Patoia L; Santucci L; Furno P; Dionisi MS; Dell'Orso S; Romagnoli M; Sattarinia A; Marini MG
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():61-7. PubMed ID: 8630640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL; Codispoti JR; Nelson EB
    Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic assessment of the effects of dipyrone (metamizol) in comparison to paracetamol and placebo on the gastric and duodenal mucosa of healthy adult volunteers.
    Bianchi Porro G; Ardizzone S; Petrillo M; Caruso I; Montrone F
    Digestion; 1996; 57(3):186-90. PubMed ID: 8739093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High-dose ranitidine protects stomach and duodenum completely against piroxicam. An endoscopic double-blind pilot study].
    Müller P; Leucht U; Simon B
    Z Gastroenterol; 1992 Dec; 30(12):851-3. PubMed ID: 1481550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
    Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
    Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alendronate on gastric and duodenal mucosa.
    Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
    Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase.
    Coruzzi G; Coppelli G; Spaggiari S; Cavestro GM; Okolicsanyi L; Lo Giudice P; Pisano C; Tepperman BL
    Dig Liver Dis; 2002 Jun; 34(6):403-10. PubMed ID: 12132787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lornoxicam, indomethacin and placebo: comparison of effects on faecal blood loss and upper gastrointestinal endoscopic appearances in healthy men.
    Warrington SJ; Debbas NM; Farthing M; Horton M; Johnston A; Thillainayagam A; Turner P; Ferber H
    Postgrad Med J; 1990 Aug; 66(778):622-6. PubMed ID: 2217030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
    Kirkova M; Alexandova A; Kesiova M; Todorov S
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):99-104. PubMed ID: 17391279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
    Girawan D; Abdurachman SA; Djumhana A; Roslia J; Pramudiyo R
    Acta Med Indones; 2004; 36(4):202-6. PubMed ID: 15673949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate].
    Guilarte López-Mañas J; Valenzuela Barranco M; Caballero Plasencia AM; Martín Ruiz JL
    Gastroenterol Hepatol; 1998 May; 21(5):212-7. PubMed ID: 9644873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in aged patients with osteoarticular diseases].
    Tavella A; Ursini G
    Clin Ter; 1997 Nov; 148(11):543-8. PubMed ID: 9494257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.
    Bias P; Buchner A; Klesser B; Laufer S
    Am J Gastroenterol; 2004 Apr; 99(4):611-8. PubMed ID: 15089890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.
    Lanza FL
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):131S-136S. PubMed ID: 3080285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
    Ehsanullah RS; Page MC; Tildesley G; Wood JR
    BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.